KIT and metabolic dysfunction-associated steatohepatitis: To determine the remedy function of C-Kit+-LSECs in NASH in vivo, we transplanted C-Kit+- or C-Kit−-BMCs into MCD-induced NASH mice (representing MCD_C-Kit+-BMC and MCD_C-Kit−-BMC group).